Surgically treated genital chronic graft-versus-host disease in women: A report of three cases

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)


Hematopoietic stem cell transplantation (HSCT) is a crucial treatment for hematological malignancy. Gonadal dysfunction occurs at an early stage after this treatment, and such patients may require hormone replacement therapy. Genital chronic graft-versus-host disease is a lesser-known complication of HSCT that begins with vulvar discomfort and dysuria and progresses to sexual dysfunction and retention of menstrual blood due to vaginal stenosis and obstruction; thus, significantly impairing the patient's quality of life. We describe three women who underwent vaginal reconstruction because of genital chronic graft-versus-host disease. We discuss the surgical techniques, including double cross plasty that were performed in each case. Surgical interventions enabled the continuation of HRT and facilitated sexual intercourse. In conclusion, gynecologists should be aware that genital chronic graft-versus-host disease can occur after HSCT, and that surgical treatment options are available to improve patients' symptoms and quality of life.

Original languageEnglish
Pages (from-to)4122-4126
Number of pages5
JournalJournal of Obstetrics and Gynaecology Research
Issue number11
Publication statusPublished - Nov 2021


  • double cross plasty
  • genital chronic graft-versus-host disease
  • hematocolpos
  • hematopoietic stem cell transplantation
  • vaginal reconstruction

ASJC Scopus subject areas

  • Obstetrics and Gynaecology


Dive into the research topics of 'Surgically treated genital chronic graft-versus-host disease in women: A report of three cases'. Together they form a unique fingerprint.

Cite this